Abstract
Deficiencies of vitamins are associated with psychiatric illnesses either by being the primary cause or an exacerbating factor. Psychiatric symptoms could also lead to poor nutrition. Vitamin deficiencies may play a role in compromising patient recovery. Vitamins are organic substances essential for several enzymatic functions. There are 13 known vitamins which are either fat soluble (4 vitamins i.e. KEDA) or water soluble (9 vitamins i.e. C, and the B group). For brain function, B-vitamins are essential in the maintenance of myelin, neuro-transmitter production and the methylation cycle. Fat-soluble vitamins are necessary in inflammatory regulation, regeneration of antioxidants and genetic modification. Vitamin deficiencies will, therefore, cause brain degeneration and will be associated with psychiatric symptoms. Few studies of vitamin deficiencies have been carried out in Sub-Saharan Africa. This chapter presents an overview of vitamins and their relation to neuropsychiatric disorders with the focus on Sub-Saharan Africa.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Page GL, Laight D, Cummings MH. Thiamine deficiency in diabetes mellitus and the impact of thiamine replacement on glucose metabolism and vascular disease. Int J Clin Pract. 2011;65(6):684–90.
Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff syndrome. Philadelphia: F.A. Davis; 1971.
Thomson AD, Marshall EJ. The natural history of Wernicke’s encephalopathy and Korsakoff’s psychosis. Alcohol Alcohol. 2006;41:151–8.
Naidoo DP, Bramdev A, Cooper K. Wernicke’s encephalopathy and alcohol-related disease. Postgrad Med J. 1991;67:978–81.
Adamolekun B, Adamolekun WE, Sonibare AD, Sofowora G. A double-blind, placebo-controlled study of the efficacy of thiamine hydrochloride in a seasonal ataxia in Nigerians. Neurology. 1994;44(3 Pt 1):549–51.
Naghashpour M, Amani R, Nutr R, et al. Riboflavin status and its association with serum hs-CRP levels among clinical nurses with depression. J Am Coll Nutr. 2011;30(5):340–7.
Pitche PT. Pellagre et érythèmes pellagroïdes, Sante 2005;15(3):205–8.
Hvas AM, Juul S, Bech P, Nexo E. Vitamin B6 level is associated with symptoms of depression. Psychother Psychosom. 2004;73(6):340–3.
Merete C, Falcon LM, Tucker KL. Vitamin B6 is associated with depressive symptomatology in Massachusetts elders. J Am Coll Nutr. 2008;27(3):421–7.
Corken M, Porter J. Is vitamin B(6) deficiency an under recognized risk in patients receiving haemodialysis? A systematic review: 2000–2010. Nephrology (Carlton). 2011;16(7):619–25.
Wilson SM, Bivins BN, Russell KA, et al. Oral contraceptive use: impact on folate, vitamin B6, and vitamin B12 status. Nutr Rev. 2011;69(10):572–83.
Coppen A, Bolander-Gouaille C. Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol. 2005;19(1):59–65.
Gilbody S, Lightfoot T, Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health. 2007;61(7):631–7.
Ezzaher A, Mouhamed DH, Mechri A, Omezzine A, Neffati F, Douki W, Bouslama A, Gaha L, Najjar MF. Hyperhomocysteinemia in Tunisian bipolar I patients. Psychiatry Clin Neurosci. 2011;65(7):664–71.
Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol. 2007;165(1):1–13.
Di Palma C, Urani R, Agricola R, et al. Is methylfolate effective in relieving major depression in chronic alcoholics? A hypothesis of treatment. Curr Ther Res Clin Exp. 1994;55(5):559–68.
Herrmann W, Lorenzl S, Obeid R. Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders: current evidence and preliminary recommendations. Fortschr Neurol Psychiatr. 2007;75(9):515–27.
Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318(26):1720–8.
Bar-Shai M, Gott D, Marmor S. Acute psychotic depression as a sole manifestation of vitamin B12 deficiency. Psychosomatics. 2011;52(4):384–6.
Vogiatzoglou A, Refsum H, Johnston C, et al. Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology. 2008;71(11):826–32.
Maktouf C, Bchir F, Louzir H, Elloumi M, Ben Abid H, Mdhaffer M, Elleuch N, Meddeb B, Mhiri C, Hassen Z, Makni F, Abid M, Cherif O, Rokbani L, Souissi T, Hafsia A, Dellagi K. Clinical spectrum of cobalamin deficiency in Tunisia. Ann Biol Clin. 2007;65(2):135–42.
Galukande M, Jombwe J, Fualal J, Baingana R, Gakwaya A. Reference values for serum levels of folic acid and vitamin B12 in a young adult Ugandan population. Afr Health Sci. 2011;11(2):240–3.
Ssonko M, Ddungu H, Musisi S. Low serum vitamin B12 levels among psychiatric patients admitted in Butabika mental hospital. BMC Res Notes. 2014;7:90.
Semeere AS, Nakanjako D, Ddungu H, Kambugu A, Manabe YC, Colebunders R. Sub-optimal vitamin B-12 levels among ART-naïve HIV-positive individuals in an urban cohort in Uganda. PLoS One. 2012;7(7):e40072.
Hathcock JN (2004) Vitamin and mineral safety, 2nd ed. Council for Responsible Nutrition (CRN).
Charlton KE, Rabinowitz TL, Geffen LN, Dhansay MA. Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. J Nutr Health Aging. 2004;8(2):99–107.
DeSantis J. Scurvy and psychiatric symptoms. Perspect Psychiatr Care. 1993;29(1):18–22.
Payne ME, Steck SE, George RR, et al. Fruit, vegetable, and antioxidant intakes are lower in older adults with depression. J Acad Nutr Diet. 2012;112(12):2022–7.
Dadheech G, Mishra S, Gautam S, et al. Oxidative stress, α-tocopherol, ascorbic acid and reduced glutathione status in schizophrenics. Indian J Clin Biochem. 2006;21(2):34–8.
Berk M, Sanders KM, Pasco JA, et al. Vitamin D deficiency may play a role in depression. Med Hypotheses. 2007;69(6):1316–9.
Eyles DW, Smith S, Kinobe R, et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21–30.
Bakare MO, Munir KM. Autism spectrum disorders (ASD) in Africa: a perspective. Afr J Psychiatry. 2011;14:208–10.
Seif Eldin A, Habib D, Noufal A, Farrag S, Bazaid K, Al-Sharbati M, et al. Use of M-CHAT for a multinational screening of young children with autism in the Arab countries. Int Rev Psychiatry. 2008;20(3):281–9.
Belhadj A, Mrad R, Halayem MB. A clinic and paraclinic study of Tunisian population of children with autism. About 63 cases. Tunis Med. 2006;84(12):763–7.
Sen CK, Khanna S, Roy S. Tocotrienol: the natural vitamin E to defend the nervous system? Ann N Y Acad Sci. 2004;1031:127–42.
Owen AJ, Batterham MJ, Probst YC, et al. Low plasma vitamin E levels in major depression: diet or disease? Eur J Clin Nutr. 2005;59(2):304–6.
Cavalier L, Ouahchi K, Kayden HJ, Di Donato S, Reutenauer L, Mandel JL, Koenig M. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet. 1998;62:301–10.
Tulloch JA, Sood NK. Vitamin E deficiency in Uganda. Am J Clin Nutr. 1967;20(8):884–97.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ssonko, M. (2015). Vitamin Deficiencies and Neuropsychiatric Disorders in Sub-Saharan Africa. In: Musisi, S., Jacobson, S. (eds) Brain Degeneration and Dementia in Sub-Saharan Africa. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2456-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2456-1_5
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2455-4
Online ISBN: 978-1-4939-2456-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)